CN1238196A - Chinese-medicinal capsule (Qianlikang bao capsule) for treating prostatitis - Google Patents
Chinese-medicinal capsule (Qianlikang bao capsule) for treating prostatitis Download PDFInfo
- Publication number
- CN1238196A CN1238196A CN 98113990 CN98113990A CN1238196A CN 1238196 A CN1238196 A CN 1238196A CN 98113990 CN98113990 CN 98113990 CN 98113990 A CN98113990 A CN 98113990A CN 1238196 A CN1238196 A CN 1238196A
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- capsule
- time
- carapax
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicinal capsule for treating prostatitis is prepared from 23 Chinese medicinal materials including coptis root, phellodendron bark, chinaroot, rehmannia root, astragalus root, etc., and features scientific prescription, widely available raw materials, high curative effect and high safety.
Description
The present invention relates to the prostatitic Chinese medicine of a kind of treatment (QIANLIEKANG health-care capsule), it is processed through repeatedly engineer testing and science by 23 prescriptions formed of flavor Chinese medicines and develops, prove by the test of pesticide effectiveness, function with clearing away heat-damp and promoting diuresis, promoting blood circulation to remove blood stasis, enriching yin and nourishing kidney, antibiotic pain relieving, be a kind of specially good effect oral medicine in urology department and the Andriatrics Dept. field, the treatment that is specially adapted to acute and chronic prostatitis, prostate hyperplasia, hyposexuality, impotence and premature ejaculation patient is used.
Prostatitis is the higher peculiar pathological changes of male's sickness rate, is that the prostatitis due to a kind of prostate nonspecific infection sexually revises.Western medical treatment is at present still based on anti-inflammation and physiotherapy, owing to lack the wholistic therapy to body, often can not effect a radical cure, the state of an illness is very easy develop into chronic.Motherland's medical science thinks that this disease is similar to " stranguria caused by overstrain ", " pyretic stranguria ", " outstanding pain ", and its diagnosis and treatment are had long history and accumulated abundant clinical experience and more complete theory, and the utmost point is treated further excavation, exploitation, arrangement, raising.We pass through series of experiment research according to its pathogeny for this reason, according to well-known doctor's prescription screening Chinese medicine, and, reached good result of use and practical value in conjunction with the Chinese herbal medicine composition prescription determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs that the modern medicine technology screening goes out to have anti inflammatory detoxication, diuretic damp eliminating and adjusting immunologic function.
Purpose of the present invention is exactly to provide a kind of prostatitic safe and reliable, Chinese medicine that curative effect is high for the treatment of for clinical.
In order to reach the purpose of the high curative effect of the present invention, except that according to experience and the modern medicine technology screening prescription, also pay special attention to the scientific technology process, it is made of by weight following component basically: Rhizoma Coptidis: Cortex Phellodendri: Radix Gentianae: Rhizoma Smilacis Glabrae: the Radix Rehmanniae: the Radix Astragali: Radix Salviae Miltiorrhizae: Radix Achyranthis Bidentatae: Radix Paeoniae Rubra: Rhizoma Chuanxiong: Poria: Rhizoma Alismatis: Cortex Moutan: Caulis Akebiae: Folium Bambusae: Pericarpium Citri Reticulatae: Radix Bupleuri: the Rhizoma Anemarrhenae: Bi : Carapax et Plastrum Testudinis: Cordyceps: Hippocampus: Spora Lygodii=1: 2: 2: 6: 3: 3: 2: 2: 2: 2: 2: 2: 2: 2: 2: 1: 2: 2: 2: 2: 1: 1: 2.
Its preparation method is:
1, gets Hippocampus, Carapax et Plastrum Testudinis, Cordyceps, Spora Lygodii according to the above ratio and be impalpable powder altogether.
2, taking by weighing Rhizoma Coptidis, Cortex Phellodendri, Radix Gentianae, Rhizoma Smilacis Glabrae, the Radix Rehmanniae, the Radix Astragali, Radix Salviae Miltiorrhizae, Radix Achyranthis Bidentatae, Radix Paeoniae Rubra, Rhizoma Chuanxiong, Poria, Rhizoma Alismatis, Cortex Moutan, Caulis Akebiae, Folium Bambusae, Pericarpium Citri Reticulatae, Radix Bupleuri, the Rhizoma Anemarrhenae, Bi according to the above ratio decocts with water three times, 3 hours for the first time, 2 hours for the second time, 1 hour for the third time, collecting decoction filters, filtrate is concentrated into relative density to be that 1.08 (80 ℃ of surveys) are put cold, add ethanol, make to contain alcohol amount and reach 40-45%, stir evenly and leave standstill, get the clear paste that supernatant concentration to relative density is 1.35 (30 ℃ of surveys).
3, with clear paste and above-mentioned fine powder mixing, drying, pulverizing, cross 100 mesh sieves, " 0 " number capsule of granulating, pack into, promptly.
Advantage of the present invention is:
1, scientific formula: promptly according to the experience prescription of distinguished veteran doctors of TCM again according to modern medicine technology screening Chinese medicine preparation, execute on the basis of controlling to have breakthrough at differential diagnosis in tcm.
2, medicine source abundance, no in great shortage, valuable product, used medical material are neither violated wild animal conservation law and are not destroyed the environmental ecology balance again.
3, technical process is simple, easy to perform is sharp promotes the use of.
4, evident in efficacy, through clinical verification, use the present invention and treat acute prostatitis, cure rate can reach 74.63%, and total effective rate is 95.6%, the treatment chronic prostatitis, cure rate is 61.75%, and total effective rate is 86.1%, in addition prostate hyperplasia, sexual impotence, premature ejaculation and some infertility is also had curative effect preferably, the present invention proves through zoopery, and is without any side effects
Describe the present invention in detail below in conjunction with embodiment:
Embodiment one: the present invention is made up of following component (by weight) basically: Rhizoma Coptidis: Cortex Phellodendri: Radix Gentianae: Rhizoma Smilacis Glabrae: the Radix Rehmanniae: the Radix Astragali: Radix Salviae Miltiorrhizae: Radix Achyranthis Bidentatae: Radix Paeoniae Rubra: Rhizoma Chuanxiong: Poria: Rhizoma Alismatis: Cortex Moutan: Caulis Akebiae: Folium Bambusae: Pericarpium Citri Reticulatae: Radix Bupleuri: the Rhizoma Anemarrhenae: Bi : Carapax et Plastrum Testudinis: Cordyceps: Hippocampus: Spora Lygodii=1: 2: 2: 6: 3: 3: 2: 2: 2: 2: 2: 2: 2: 2: 2: 1: 2: 2: 2: 2: 1: 1: 2;
Its preparation method is:
1, gets Hippocampus 50g, Carapax et Plastrum Testudinis 100g, Cordyceps 50g, Spora Lygodii 100g according to the above ratio and be impalpable powder altogether.
2, all the other take by weighing Rhizoma Coptidis 50g according to the above ratio, Cortex Phellodendri 100g, Radix Gentianae 100g, Rhizoma Smilacis Glabrae 300g, Radix Rehmanniae 150g, Radix Astragali 150g, Radix Salviae Miltiorrhizae 100g, Radix Achyranthis Bidentatae 100g, Radix Paeoniae Rubra 100g, Rhizoma Chuanxiong 100g, Poria 100g, Rhizoma Alismatis 100g, Cortex Moutan 100g, Caulis Akebiae 100g, Folium Bambusae 1 00g, Pericarpium Citri Reticulatae 50g, Radix Bupleuri 100g, Rhizoma Anemarrhenae 100g, Bi 100g decocts with water three times, 3 hours for the first time, 2 hours for the second time, 1 hour for the third time, collecting decoction filters, it is that 1.08 (80 ℃ of surveys) are put cold that filtrate is concentrated into relative density, add ethanol, make to contain alcohol amount and reach 40-45%, stir evenly and leave standstill, getting supernatant concentration to relative density is the clear paste of 1.35 (30 ℃ of surveys).
3, with clear paste and above-mentioned fine powder mixing, drying, pulverizing, cross 100 mesh sieves, " 0 " number capsule of granulating, pack into, promptly.
Claims (1)
1, the prostatitic Chinese medicine of a kind of treatment, it is characterized in that it basically by following component by weight forming: Rhizoma Coptidis: Cortex Phellodendri: Radix Gentianae: Rhizoma Smilacis Glabrae: the Radix Rehmanniae: the Radix Astragali: Radix Salviae Miltiorrhizae: Radix Achyranthis Bidentatae: Radix Paeoniae Rubra: Rhizoma Chuanxiong: Poria: Rhizoma Alismatis: Cortex Moutan: Caulis Akebiae: Folium Bambusae: Pericarpium Citri Reticulatae: Radix Bupleuri: the Rhizoma Anemarrhenae: Bi : Carapax et Plastrum Testudinis: Cordyceps: Hippocampus: Spora Lygodii=1: 2: 2: 6: 3: 3: 2: 2: 2: 2: 2: 2: 2: 2: 2: 1: 2: 2: 2: 2: 1: 1: 2;
The extracting mode of its raw material is:
(1) get according to the above ratio Hippocampus, Carapax et Plastrum Testudinis, Cordyceps, Spora Lygodii, be impalpable powder altogether;
(2) all the other 19 flavor Chinese medicines take by weighing according to the above ratio and decoct with water three times, and 3 hours for the first time, 2 hours for the second time, 1 hour for the third time, collecting decoction, filtration, concentrated were put cold, add ethanol, make to contain the alcohol amount and reach 40-45%, stir evenly, leave standstill, get the clear paste of supernatant concentration;
(3) qinghuo reagent and above-mentioned fine powder mixing, drying, pulverized 100 mesh sieves, granulate, incapsulate, promptly.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 98113990 CN1238196A (en) | 1998-05-15 | 1998-05-15 | Chinese-medicinal capsule (Qianlikang bao capsule) for treating prostatitis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 98113990 CN1238196A (en) | 1998-05-15 | 1998-05-15 | Chinese-medicinal capsule (Qianlikang bao capsule) for treating prostatitis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1238196A true CN1238196A (en) | 1999-12-15 |
Family
ID=5223676
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 98113990 Pending CN1238196A (en) | 1998-05-15 | 1998-05-15 | Chinese-medicinal capsule (Qianlikang bao capsule) for treating prostatitis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1238196A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1294954C (en) * | 2004-03-12 | 2007-01-17 | 天津中新药业集团股份有限公司隆顺榕制药厂 | Medicine for treating urethra infestation and prostatitis and its preparation method |
CN100413520C (en) * | 2006-06-13 | 2008-08-27 | 胡广德 | Medicine for treating prostatitis |
CN100457152C (en) * | 2006-02-08 | 2009-02-04 | 南京蓝本科技有限公司 | Chinese medicinal composition for treating chronic prostatitis, its preparation method and purpose |
CN101623457B (en) * | 2009-07-31 | 2011-06-29 | 程立法 | Traditional Chinese medicine for treating chronic prostatitis |
CN105434684A (en) * | 2015-12-31 | 2016-03-30 | 河南弘烨生物科技有限公司 | Abelmoschus manihot flower containing traditional Chinese medicine preparation for preventing and treating prostate disease and preparation method of traditional Chinese medicine preparation |
-
1998
- 1998-05-15 CN CN 98113990 patent/CN1238196A/en active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1294954C (en) * | 2004-03-12 | 2007-01-17 | 天津中新药业集团股份有限公司隆顺榕制药厂 | Medicine for treating urethra infestation and prostatitis and its preparation method |
CN100457152C (en) * | 2006-02-08 | 2009-02-04 | 南京蓝本科技有限公司 | Chinese medicinal composition for treating chronic prostatitis, its preparation method and purpose |
CN100413520C (en) * | 2006-06-13 | 2008-08-27 | 胡广德 | Medicine for treating prostatitis |
CN101623457B (en) * | 2009-07-31 | 2011-06-29 | 程立法 | Traditional Chinese medicine for treating chronic prostatitis |
CN105434684A (en) * | 2015-12-31 | 2016-03-30 | 河南弘烨生物科技有限公司 | Abelmoschus manihot flower containing traditional Chinese medicine preparation for preventing and treating prostate disease and preparation method of traditional Chinese medicine preparation |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102512590B (en) | Chinese medicine for treating reversible pulpitis and preparation method thereof | |
CN1065134C (en) | Quick-acting preparation for litholysis | |
CN102988905B (en) | Traditional Chinese medicine preparation for treating epilepsia and preparation method thereof | |
CN1178675C (en) | Toxin-discharging liver-fortifying medicine | |
CN1436564A (en) | Liver cancer treating medicine and its prepn | |
CN1181849C (en) | Gastropathy treating Chinese medicine | |
CN101474361A (en) | Chinese medicine for treating cerebropathy | |
CN100490836C (en) | Medicine composition for treating osseous arthritis, and its preparation method | |
CN1238196A (en) | Chinese-medicinal capsule (Qianlikang bao capsule) for treating prostatitis | |
CN101822780A (en) | Medicament for treating oral ulcer and preparation method thereof | |
CN1159037C (en) | Medicine for treating apoplexy | |
CN1233483A (en) | Traditional Chinese medicine for treating cirrhosis and liver cancer | |
CN1077896A (en) | Medicine for psoriasis and manufacture method | |
CN1365822A (en) | 'Shugan Lidan' capsule and its preparing process | |
CN1517115A (en) | Chinese patent drug-Fuyan capsdule for treating chronic pelvic inflammation | |
CN101181516B (en) | Chinese medicine prescription orally taken for curing leukaemia | |
CN105797092B (en) | Yiyuan anti-cold mixture | |
CN1141780A (en) | Human-body purifying agent | |
CN1634194A (en) | Genital disease treating Chinese medicine | |
CN1113804A (en) | Antianemic powder and its preparing method | |
CN1130529A (en) | Aizikangfuning-Chinese patent drug for treating AIDS and preparing process thereof | |
CN1194733C (en) | Medicine for treating hyperthyroidism and its prepn | |
CN1153044A (en) | Thyroid gland pill and producing process thereof | |
CN1068217C (en) | Traditional Chinese medicine for treating skin disease and veneral disease | |
CN101480486A (en) | Three-period Chinese medicine for detoxification and technique for preparing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C01 | Deemed withdrawal of patent application (patent law 1993) | ||
WD01 | Invention patent application deemed withdrawn after publication |